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ABSTRACT: 
Examination of haematological profile is useful for baseline assessment, treatment monitoring and prognostic evaluation in 
Hiv/AIDS management. The objectives of the study was to assess the haematological profile of HIV seropositive HAART 
naive patients who attended Kogi State University Teaching Hospital, Anyigba, Kogi State, Nigeria between January 1, 2014 
and December 31, 2014. The study was prospective experimental research. Ethical clearance was obtained from ethical 
committee of Kogi State University Teaching Hospital, Anyigba. Written and verbal informed consent was taken from all 
patients. A total of 404 HIV seropositive HAART naive patients comprising 147 (36.4%) males and 257(63.6%)females were 
examined. The overall mean age of patients was 33.0 ±12.7 years and female-male ratio was 1.7: 1.  Half of respondents 
200(50.4%) accessed HIV care and treatment for the time in stage three HIV disease.   Patients had overall mean CD4 cells count 
of 381.8  ± 240.8 cells/mm3 , white blood cells count of 5.8 ± 3.6 × 109/L, lymphocyte count 2.3 ±1.3, granulocyte count 0.8 ± 0.8 
and platelet count of  260.0 ± 109.1 × 109/L. The mean packed cell volume was 34.1± 5.9 %, haemoglobin 11.3 ± 2.1 g/dl and mean 
corpuscular haemoglobin concentration was 31.5 ± 14.3 g/dl.    The packed cells volume (p=0.0001, T test= 4.0259) and 
haemoglobin (p=0.0001, T test= 4.1534) profiles of HIV clients were respectively statistically significance with gender, while 
CD4 cells count ( p=0.004, F= 4.523) and platelet count (p= 0.008, F = 3.974) were significance respectively with HIV disease 
staging.  The study recommended the need for awareness programs, nutritional education and micronutrients supplementation 
including multivitamins for HIV clients. 
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RESUME                                                                                                                                                                                                                     
L’examen du profil hématologique pour l’évaluation de base, le contrôle du traitement et de l’évaluationpronostique dans la 
gestion du VIH/SIDA. Le but de l’étude était d’évaluer le profil hématologiquedes HAART séropositifs au VIH chez les 
patients naïfs qui fréquentaient l’hôpital universitaire d’état de Kogi, Anyigba, état de Kogi, Nigeria entre 1er janvier, 2014 et 
31emedécembre, 2014. L’étude était la recherche expérimentale prospective. L’approbation éthique a été obtenue  du comité de 
l’hôpital universitaire d’état de Kogi, Anyigba. Le consentement informé verbal et écrit a été prise de tous les patients. Un total 
de 404 VIH séropositifs HAART patients naïfs comprenant 147 (36,4%) hommes et 257 (63,6%) femmes ont été examinés. L’âge 
moyenglobale des patients était de 33,0 ±12,7 ans et le ratio femme – homme était 1,7 : 1. La moitié des répondants 200 (50,4%) 
ont accédé les soins et le traitement du VIH pour le moment à la troisième phase de la maladie de VIH.Les patients avaient la 
numération moyenne globale des cellules CD4 de 381,8 ± 240,8 cellules/mm3, numération des globules blancs de 5,8 ± 3,6 x 
109/L, nombre de lymphocyte 2,3 ± 1,3, nombre de granulocyte  0,8 ± 0,8 et numération plaquettaire de 260,0 ± 109,1 x 109/L.  Le 
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volume cellulaire moyen emballé était 34,1 ± 5,9%, hémoglobine 11,3 ± 2,1 g/dl et la concentration corpusculaire moyenne en 
hémoglobine était 31,5 ± 14,3 g/dl. Le volume des cellules emballés (p=0,0001,  T test = 4,0259) et les profilsd’hémoglobines 
(p=0,0001,  T  test =  4,1534) des clients VIH étaient respectivement statistiquement significative avec le sexe tandis que la 
numération des cellules CD4 (p=0,004,   F= 4,523) et la numération plaquettaire (p= 0,008,     F= 3,974) étaient respectivement 
signification avec le stade de la maladie VIH. L’étude a recommandé la nécessité pour les programmes de sensibilisation, 
l’éducation nutritionnelle et micronutriments supplémentation y compris des multi vitamines pour les clients du VIH. 
Mots clés : Hématologique, VIH, HAART, KSUTH, Nigeria. 
 
INTRODUCTION                                                                
The World Health Organization (WHO) and United 
Nations Agency for International Development 
(UNAID) in 2013 reported that about 35 million 
people worldwide and 3.4 million Nigerian were 
living with human immune deficiency virus (HIV). 
HIV has a great prediction for the CD4 glycoprotein 
receptor on the surface of immune cells such as the T 
helper cells, monocytes, macrophages and dentritic 
cells[4-7]. Examination of haematological profile 
especially  packed cell volume (PCV), haemoglobin 
(Hb), mean corpuscular volume (MCV), mean 
corpsular Haemoglobin concentration (MCHC), CD4 
Count, white blood cell count (WBC) and platelet 
count are cardinal as baseline assessment, treatment 
monitoring and prognostic evaluation in HIV/AIDs 
management[8-16].  Anaemia is the most common 
cytopenia in HIV complication and is characterized 
by  packed cells volume (PCV) less than 30%, 
haemoglobin below 10milligram/deciliter and 
typically of normochromic and normocytic 
morphology in 10–20% of patients with HIV infection 
at diagnosis and the prevalence can range from 66–
85% during the course of the disease[8,17,18]. 
Common causes of normocytic anaemia in HIV 
patients are chronic diseases, infectious agents such 
as parvovirus B19 or Mycobacterium avium complex 
(MAC), thrombotic thrombocytopenic purpura 
(TTP), drug toxicities, autoimmunity and 
hypersplenism[19-21].  The main mechanism of 
anaemia of chronic disease is due to haemopoiesis 
suppression  of marrow progenitors by HIV infected 
T cells[22]. 
Microcytic anaemia with mean corpuscular volume 
(MCV) below 80 femto litres are described in HIV 
patients with iron deficiency anaemia as sequelae of   
hookworm parasitic infestation, intestinal 
malabsorption (Giardiasis, Crytosporidosis), lactose 
intolerance (chronic infection), gastrointestinal 
bleeding (shigellosis, amoebiasis) and nutritional 
deficiency[19,23,24].  Megaloblastic or macrocytic 
anaemia are uncommon except in HIV infected 
patients on zidovudine, cotrimoxazole and cytotoxic 
drug therapy[19].  Most patients develop 
macrocytosis after 2 weeks of zidovudine initiation 
and have mean corpscular volume (MCV) greater 
than 110 femoliters[19]. Macrocytosis can be used as 
a prognostic  marker of zidovdine adherent though is 
dose dependent and correlate with the climax stage 
of the disease[19].  The mechanism of megaloblastic 
anaemia in HIV infected patients on cotrimoxazole 
therapy is attributed to folate antagonism especially 
in patients with nutritional deficiency[19].  Anaemia 
and hypochromic red cells morphological pattern 
were reported  in HIV clients among iron deficiency 
and thalassemic patients, while  hyperchromia were 
described among sickle cell disease and hereditary 
spherocytosis.  Anisocytosis, poikilocytosis and 
rouleaux formation has also  been noted in the 
peripheral blood films of some HIV patients[25-27].  
Granulocytopenia including neutropenia and 
abnormal granulocyte functions are problems 
commonly encountered in patients with HIV 
infection[28-29].   Neutropenia (Neutrophil count 
below 1.5 x 109/L may occur in 10-30% of HIV 
patients typically with advanced disease.  The 
pathogenesis of granulocytopenia in patients with 
HIV infections is multi-factorial.  The mechanism 
may involves direct effect of HIV infection in the 
bone marrow, opportunistic infections 
(cytomegalovirus, mycobacterium avivum complex, 
tuberculosis, histoplasmosis and leishmaniasis), auto 
immune disease, infiltrative disorders (infection, 
maligancy) and drug toxicity (zidovudine, 
starvudine, Cotrimoxazole and antituberculous; 
ironiazid, rifampicin and rifabution)[28-29].  
The other morphological findings observed in HIV 
infection include hypogranular giant meta 
myelocyte, toxic granulation, dohle bodies and 
cytoplasmic vacuolation in the peripheral blood 
smear.  The CD4 T lymphocyte count in HIV infected 
patients  were described to relate or correlate with 
the degree of immune suppression and the clinical 
stage of the patients.  A normal CD4 T lymphocyte 
count in a healthy, HIV negative adult   is usually 
between 500 and 1500 cells per cubic millimeter of 
blood[30].  In people with untreated HIV infection, 
the CD4 cells count decline by approximately 50–80 
cells per cubic millimeter per year.  The pattern of 
decline may be slow and steady or the CD4 cells 
count may level off for an extended period of time 
and then decrease[31]. 
Thrombocytopenia  occurs in 15-60% of patients with 
AIDs and is seen in 10% of patients at early stage of 
HIV infection. The thrombocytes are usually of 
normal morphology except where there is immune 
destruction.  The possible aetiologies of 
thrombocytopenia in  HIV infection include immune 
mediated destruction, thrombocytopenic purpura, 
impaired haemopoicsis, drug toxicity (heparin, 
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quinidine), alcoholism, splenomegaly and liver 
disease[31-32]. 
The objective of the research was to study the 
haematological profile of HIV seropositive HAART 
naïve patients in Kogi State University Teaching 
Hospital Anyigba between January1, 2014 to 
December 31, 2014. 
MATERIALS AND METHODS                                                                                                                                           
Materials used were Sysmex XP 300 haematology 
analyzer, XP300 cell pack, stromatolyser cellclean, 
eightcheck 3WP, JIK solution, 7½ surgical gloves, 
cottonwool and methylated spirit.  Other materials 
were partec cyflow counter cylometer, partec 
cleaning, sheat and decontamination fluids.  The 
materials also include partec CD4 and CD4% easy 
count kits, rohren tubes, pipettes, tubes rack, EDTA 
tubes (5mls), determine HIV Test kits with LOT 
number 38099k300 and unigold HIV test kits with 
LOT number 2010143.  The research was 
prospective and experimental study that was 
conducted between January 1, 2014 to December 31, 
2014.  404 HIV seropositive clients who attended  
Kogi State University Teaching Hospital Anyigba 
after screening with determine and umgold HIV test 
kits were studied.  Ethical approval for the study 
was obtained from the Ethical committee of the Kogi 
State University Teaching Hospital Anyigba Kogi 
State Nigeria.   
TABLE 1: DISTRIBUTION OF RESPONDENTS BY DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
(A) Age distribution of respondents: 
 
Age   Frequency 404(100%) 
0-9  22(5.4) 
10-19  13(3.2) 
20-29  125(30.9) 
30-39  140(34.7) 
40-49  64(15.8) 
50-59  28(6.9) 
>60  12(3.0) 
 
 
(B) Distribution of respondents by gender: 
 
Gender   Frequency 404(100%) 
Male   147(36.4) 
Female   257(63.6) 
(C) Distribution of respondents by HIV disease stage:  
 
Clinical Stage Frequency 404(100%)  
1          72(18.1) 
2          121(30.9) 
3          200(50.4) 
4         11(2.7) 
 
Verbal and written informed consent was obtained 
from all patients. History and examination was 
conducted on all patients to obtain biodata, weight, 
clinical staging and risk of opportunistic infections 
including pulmonary tuberculosis. Whole blood 
sample was collected between 8.00am to 10.00am by 
veno- puncture into 5ml vacutainer tubes containing 
EDTA anticoagulant and processed within 4hours of 
collection.  Sysmex XP– 300TM automated hematology 
analyzer was used after calibration to estimate 
packed cell volume (PCV), haemoglobin (Hb), mean 
corpscular haemoglobin concentration (MCHC), 
whole blood cells (WBC), granulocytes, lymphocytes, 
eosinophils and platelet counts.  Flow cytometry 
using partec cyclow counter flow cylometer was used 
to determine CD4 T lymphocyte.  Data analysis was 
done using SPSS version 20 statistical software.  The 
study was conducted at a predetermined  p<0.05 and 
95% confidential interval.  Data were generated into 
cross tabulations, T test and analysis of 
variance(ANOVA) were conducted to determine 
statistical significance among the variables. 
RESULTS                                                                                                                                                                                                
A total of 404 HIV seropositive HAART naive 
patients comprising 147 (36.4%) males and 
257(63.6%) females were examined. The overall mean 
age of patients was 33.0 ±12.7 years and female-male 
ratio was 1.7: 1.  Half of respondents 200(50.4%) 
accessed HIV care and treatment for the time in stage 




TABLE 2: THE BASELINE MEAN HAEMATOLOGICAL PROFILE OF HIV SEROPOSITIVE HAART NAIVE CLIENTS IN 
KSUTH, ANYIGBA, KOGI STATE 
HAEMATOLOGIC PROFILE DISTRIBUTION OF MEAN AND STANDARD 
DEVIATION  
CD4 381.8 ± 240.8 Cells /mm3 
WBC 5.8 ± 3.6    x     109/L 
Lymphocyte  2.3 ± 1.3 
Granulocyte  0.8 ± 0.8  
Platelet 260.0 ± 109.1 x 109/L 
PCV       34.1 ± 5.9%     
Haemoglobin 11.3 ± 2.1 g/dl 
MCHC 31.5 ± 14.3 g/dl 
 
TABLE 3: THE DISTRIBUTION OF HAEMATOLOGICAL PROFILE OF HIV SEROPOSITIVE HAART NAÏVE CLIENT 








PLATELET PCV HB MCHC 
1(n=72) 464.6±258.0 5.7±2.2 2.4±1.3 0.62±0.5 255.2±109.2 35.0±6.3 11.4±2.2 30.9±1.1 
2(n=121) 390.9±219.7 6.4±5.4 2.3±1.3 0.8±0.8 225.3±97.7 34.5±4.8 11.4±1.9 33.3±26.0 
3(n=200) 346.0±238.5 5.5±2.5 2.2±1.2 0.8±0.8 263.4±116.4 33.6±6.3 11.1±2.2 30.6±1.3 
4(n=11) 390.9±242.9 5.8±3.0 2.9±2.1 0.7±0.4 304.3±104.8 31.7±6.0 10.6±2.0 31.3±2.2 
F Test 4.523 1.602 1.344 1.165 3.974 1.836 0.998 0.948 
P value 0.004 0.188 0.260 0.323 0.008 0.140 0.394 0.417 




  Patients had overall mean CD4 cells count of 381.8  ± 
240.8 cells/mm3 , white blood cells count of 5.8 ± 3.6 
× 109/L, lymphocyte count 2.3 ±1.3, granulocyte 
count 0.8 ± 0.8 and platelet count of  260.0 ± 109.1 × 
109/L. The mean packed cell volume was 34.1± 5.9 
%, haemoglobin 11.3 ± 2.1 g/dl and mean 
corpuscular haemoglobin concentration  was 31.5 ± 
14.3 g/dl. The packed cells volume (p=0.0001, T 
test= 4.0259) and haemoglobin (p=0.0001, T test= 
4.1534) profiles of HIV clients were respectively 
statistically significance with gender, while CD4 cells 
count ( p=0.004, F= 4.523) and platelet count (p= 
0.008, F = 3.974) were significance respectively with 
HIV disease staging. 
 
 
TABLE 4: THE GENDER DISTRIBUTION OF BASELINE HAEMATOLOGICAL PROFILE OF HIV SEROPOSITIVE HAART 
NAÏVE CLIENT IN KSUTH, ANYIGBA, KOGI STATE 












377.2±181.9 5.94±3.2 2.36±1.6 0.8±1.0 262.6±131.7 35.6±6.5 11.8±2.4 32.8±23.6 
Female 
257(63.6) 
384.4±245.0 5.8±3.9 2.2±1.1 0.7±0.7 258.6±94.3 33.2±5.3 10.9±1.9 30.7±1.1 
TOTAL 
404(100) 
381.8±240 5.8±3.6 2.3±1.3 0.8±0.8 260.0±109.1 34.1± 5.9 11.3±2.1 31.5±14.3 
T Test 0.3106 0.3698 1.1866 1.1768 0.3537 4.0259 4.1534 1.4251 
Df 402 402 402 402 402 402 402 402 
P value 0.756 0.712 0.2361 0.240 0.7238 0.0001 0.0001 0.1549 
 
DISUSSION                                                                          
Two third of HIV clients were found in the 20 – 39 
years age group categories.  This finding was 
collaborated in many comparative studies[34-44].  
Most respondents belonged to the female gender.  
The female genital anatomy was reported to increase 
the risk of sexually transmitted infection including 
AIDs[41].  Access to reproductive health including 
HIV treatment and care was noticed to be higher in 
female than males[42].   Half of the HIV client 
presented at the facility for the first time in HIV 
disease stage three to access treatment .  This 
observation of client presentation in advance HIV 
disease  when complications have developed was 
reported in sexually transmitted infection clinic in Ile 
Ife by Olayinka[38].    Stigmatization, ignorance, 
belief and poor health seeking behavior were among 
many reasons attributed to such behavior. The mean 
CD4 cell count was low among HIV clients, while the 
CD4 profile based on the HIV disease staging was 
statistically significance (p=0.004) in this study.   This 
observation was also reported by many  
 
Researchers [43-44].   CD4 lymphocyte cells also 
known as T cells or T helper cells are the primary 
targets of HIV [45]. The degree of immuno-
suppression as assessed by the CD4 cell counts closely 
correlates with the HIV disease stage as reported in 
past studies[43-44].   The mean white blood cells 
count, granulocyte and platelet counts in this study 
lied within normal limit. The client's HIV disease 
staging was statistically significance with platelet 
count (p=0.008).  Some researchers in their separate 
studies observed leucopenia, granulocytopenia and 
thrombocytopenia in patients with HIV 
infection[10,15,46].  Cytopenias are one of the most 
common complications of HIV.  The mechanism of 
cytopenia in HIV clients is multi-factorial in 
dimension.   The mechanisms were described to relate 
with direct effect of HIV on the bone marrow, 
opportunistic infections, autoimmune diseases, 
infiltrative disorders and dry toxicity [28-29].  
However, lymphocyte count in this study  was found 
to be high.  This study recorded low mean packed cell 
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volume and haemoglobin concentration,  which also 
correspond to findings obtained by many researchers 
[21,47-49]. The profile of packed cells volume and 
haemoglobin based on gender in this study were 
statistically  significance (p= 0.0001).  The main 
mechanism of anaemia of chronic disease is due to 
haemopoiesis suppression caused from direct 
suppression of bone marrow progenitors by HIV 
infected T cells.  In this study the mean corpsular 
haemoglobin concentration (MCHC) was within 
normal limit. This finding was however in contrast to 
low MCHC value recorded by Osunkalu [50].        
 CONCLUSION                                                                       
Most clients in this study were youth in the 20- 39 
years age category and presented for the first time in  
HIV disease  stage three. The clients have low mean 
CD4 cells count, packed cells volume and 
haemoglobin profile. Gender was statistically 
significance with packed cells volume and 
haemoglobin,  while the client's HIV disease staging  
was significance with CD4 cells and platelet counts. 
This study recommended the need for awareness 
campaigns, nutritional education and micronutrients 
supplementation including multivitamins for HIV 
clients. 
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